HomeBBN • SWX
add
Bellevue Group AG
Nakaraang pagsara
CHF 14.75
Sakop ng araw
CHF 14.50 - CHF 14.80
Sakop ng taon
CHF 11.05 - CHF 24.30
Market cap
195.19M CHF
Average na Volume
9.95K
P/E ratio
13.08
Dividend yield
7.93%
Primary exchange
SWX
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
(CHF) | Hun 2024info | Y/Y na pagbabago |
---|---|---|
Kita | 18.41M | -11.31% |
Gastos sa pagpapatakbo | 13.73M | -10.56% |
Net na kita | 3.72M | -7.22% |
Net profit margin | 20.18 | 4.61% |
Kita sa bawat share | — | — |
EBITDA | — | — |
Aktuwal na % ng binabayarang buwis | 17.26% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
(CHF) | Hun 2024info | Y/Y na pagbabago |
---|---|---|
Cash at mga panandaliang investment | 30.49M | 100.63% |
Kabuuang asset | 138.75M | -4.69% |
Kabuuang sagutin | 22.05M | -24.81% |
Kabuuang equity | 116.70M | — |
Natitirang share | 13.20M | — |
Presyo para makapag-book | 1.67 | — |
Return on assets | 10.71% | — |
Return on capital | — | — |
Cash Flow
Net change in cash
(CHF) | Hun 2024info | Y/Y na pagbabago |
---|---|---|
Net na kita | 3.72M | -7.22% |
Cash mula sa mga operasyon | 3.65M | 137.31% |
Cash mula sa pag-invest | — | — |
Cash mula sa financing | -8.10M | 45.85% |
Net change in cash | -4.17M | 83.13% |
Malayang cash flow | — | — |
Tungkol
Bellevue Group AG, headquartered in Zurich, is a listed investment management corporation from Switzerland. Bellevue Group consists of the subsidiaries Bellevue Asset Management, Bellevue Private Markets and StarCapital. It has 9,6 billion Swiss francs Assets Under Management Around 80% of clients assets are in healthcare investments. Bellevue Group is also active in alternative investments and private equity, including co-investments in private domestic small and medium-sized enterprises. In this business area, client assets under management were 1.0 billion francs as of mid-2021.
Bellevue Group is among the largest investors in the health care segment worldwide. It has subsidiaries in Germany, UK and USA, and is focusing on platform companies with products in phase two trials or later who preferably develop technologies that can be applied in multiple ways. One of the Bellevue Asset Management teams manages the BB Biotech investment company. The former investment company BB Medtech, which was converted into an equity fund at the end of September 2009, is also managed by Bellevue Asset Management. Wikipedia
CEO
Itinatag
1993
Website
Mga Empleyado
88